Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INDAMS: Indapamide in Progressive Multiple Sclerosis
NCT07765212Phase 2Not yet recruiting
- Sponsor
- Eva M.M. Strijbis
- Start
- Sep 2026
- Primary completion
- Sep 2028
01
Overview
A Phase 2 trial of indapamide in primary progressive multiple sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), sponsored by Eva M.M. Strijbis. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
indapamide
03
Conditions
primary progressive multiple sclerosis (PPMS)Secondary Progressive Multiple Sclerosis (SPMS)
Beyond the preview
Go deeper on NCT07765212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07765212.